Wegovy is a glucagon-like peptide 1 receptor agonist (GLP1-RA) injectable therapy approved by the Federal Drug Administration (FDA) for chronic weight management in adults who are obese or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
Kovalcsik R, Devlin T, Loux S, Martinek M, May J, Pickering T, et al
Originally christened Sunapee , she was renamed after Lake Minnetonka, Minnesota, and commissioned as a patrol gunboat with ID number WPG-67 on 11 July 1946
In Arabidopsis seedlings, both sub- as well as supraoptimal folates lead to root stunting (Li et al
The findings improve our understanding of how increasingly prevalent GLP-1s may influence human behavior and identify new opportunities to potentially enhance treatment
However, challenges such as gastrointestinal side effects and high medication costs are limiting broader accessibility